Login
Home
Charts
Search
Watchlist
Products

Epigral Ltd

EPIGRAL·NSE
1,093.60-0.66%Wed, 23 Sept '26 15:53

Epigral Ltd

EPIGRAL
NSE
1,093.60
-0.66%
|Wed, 23 Sept '26 15:53
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
4,711Cr
Close
Close Price
1,092.00
Industry
Industry
Pesticides/Agrochemicals
PE
Price To Earnings
17.38
PS
Price To Sales
1.79
Revenue
Revenue
2,626Cr
Rev Gr TTM
Revenue Growth TTM
4.81%
PAT Gr TTM
PAT Growth TTM
-37.34%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
478472525651626645628607587597736705
Growth YoY
Revenue Growth YoY%
-13.9-12.3-6.743.230.936.819.6-6.9-6.2-7.517.316.3
Expenses
ExpensesCr
370349369475448463454443455494568526
Operating Profit
Operating ProfitCr
108123155176178183173163132103169179
OPM
OPM%
22.626.029.627.128.528.327.626.922.517.222.925.4
Other Income
Other IncomeCr
1222644916-25
Interest Expense
Interest ExpenseCr
2120141427012232211167
Depreciation
DepreciationCr
323130333233344242434243
PBT
PBTCr
56741131311251541311077055110134
Tax
TaxCr
18253645445044-5418152934
PAT
PATCr
384977868110487161513981100
Growth YoY
PAT Growth YoY%
-58.5-36.40.7172.5114.0111.212.487.1-37.0-62.3-6.8-37.9
NPM
NPM%
8.010.414.713.213.016.113.826.58.76.511.014.1
EPS
EPS
9.111.818.620.719.624.320.137.311.99.118.823.1
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
478472525651626645628607587597736705
Growth YoY
Revenue Growth YoY%
-13.9-12.3-6.743.230.936.819.6-6.9-6.2-7.517.316.3
Expenses
ExpensesCr
370349369475448463454443455494568526
Operating Profit
Operating ProfitCr
108123155176178183173163132103169179
OPM
OPM%
22.626.029.627.128.528.327.626.922.517.222.925.4
Other Income
Other IncomeCr
1222644916-25
Interest Expense
Interest ExpenseCr
2120141427012232211167
Depreciation
DepreciationCr
323130333233344242434243
PBT
PBTCr
56741131311251541311077055110134
Tax
TaxCr
18253645445044-5418152934
PAT
PATCr
384977868110487161513981100
Growth YoY
PAT Growth YoY%
-58.5-36.40.7172.5114.0111.212.487.1-37.0-62.3-6.8-37.9
NPM
NPM%
8.010.414.713.213.016.113.826.58.76.511.014.1
EPS
EPS
9.111.818.620.719.624.320.137.311.99.118.823.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
8291,5512,1881,9292,5502,5272,626
Growth
Revenue Growth%
87.241.1-11.832.2-0.94.8
Expenses
ExpensesCr
5671,0411,4991,4481,8391,9602,043
Operating Profit
Operating ProfitCr
261509689481711567583
OPM
OPM%
31.532.931.524.927.922.422.2
Other Income
Other IncomeCr
2487161410
Interest Expense
Interest ExpenseCr
29446673537256
Depreciation
DepreciationCr
7486109124133168170
PBT
PBTCr
161383522291541341367
Tax
TaxCr
6013116995183996
PAT
PATCr
101253353196358332271
Growth
PAT Growth%
150.739.8-44.682.6-7.2-37.3
NPM
NPM%
12.216.316.110.214.013.110.3
EPS
EPS
24.360.885.047.184.777.062.8
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
8291,5512,1881,9292,5502,5272,626
Growth
Revenue Growth%
87.241.1-11.832.2-0.94.8
Expenses
ExpensesCr
5671,0411,4991,4481,8391,9602,043
Operating Profit
Operating ProfitCr
261509689481711567583
OPM
OPM%
31.532.931.524.927.922.422.2
Other Income
Other IncomeCr
2487161410
Interest Expense
Interest ExpenseCr
29446673537256
Depreciation
DepreciationCr
7486109124133168170
PBT
PBTCr
161383522291541341367
Tax
TaxCr
6013116995183996
PAT
PATCr
101253353196358332271
Growth
PAT Growth%
150.739.8-44.682.6-7.2-37.3
NPM
NPM%
12.216.316.110.214.013.110.3
EPS
EPS
24.360.885.047.184.777.062.8

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
424242424343
Reserves
ReservesCr
4326841,0281,2131,8612,178
Current Liabilities
Current LiabilitiesCr
389532648780496710
Non Current Liabilities
Non Current LiabilitiesCr
376865715761752573
Total Liabilities
Total LiabilitiesCr
1,4492,1242,4322,7943,1523,505
Current Assets
Current AssetsCr
181447420502775827
Non Current Assets
Non Current AssetsCr
1,2671,6772,0132,2922,3772,679
Total Assets
Total AssetsCr
1,4492,1242,4322,7943,1523,505
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
424242424343
Reserves
ReservesCr
4326841,0281,2131,8612,178
Current Liabilities
Current LiabilitiesCr
389532648780496710
Non Current Liabilities
Non Current LiabilitiesCr
376865715761752573
Total Liabilities
Total LiabilitiesCr
1,4492,1242,4322,7943,1523,505
Current Assets
Current AssetsCr
181447420502775827
Non Current Assets
Non Current AssetsCr
1,2671,6772,0132,2922,3772,679
Total Assets
Total AssetsCr
1,4492,1242,4322,7943,1523,505

Cash Flow

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
229284626398441436
Investing Cash Flow
Investing Cash FlowCr
-197-455-437-401-262-355
Financing Cash Flow
Financing Cash FlowCr
-32195-200-8-164-94
Net Cash Flow
Net Cash FlowCr
124-11-1115-14
Free Cash Flow
Free Cash FlowCr
32-172210-125450
CFO To PAT
CFO To PAT%
227.3112.3177.2203.0123.2131.2
CFO To EBITDA
CFO To EBITDA%
87.755.790.982.662.076.8
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
229284626398441436
Investing Cash Flow
Investing Cash FlowCr
-197-455-437-401-262-355
Financing Cash Flow
Financing Cash FlowCr
-32195-200-8-164-94
Net Cash Flow
Net Cash FlowCr
124-11-1115-14
Free Cash Flow
Free Cash FlowCr
32-172210-125450
CFO To PAT
CFO To PAT%
227.3112.3177.2203.0123.2131.2
CFO To EBITDA
CFO To EBITDA%
87.755.790.982.662.076.8

Ratios

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4,0463,9194,5548,1923,4934,711
Price To Earnings
Price To Earnings
16.011.123.322.910.517.4
Price To Sales
Price To Sales
2.61.82.43.21.41.8
Price To Book
Price To Book
5.63.73.64.31.62.1
EV To EBITDA
EV To EBITDA
9.86.911.412.37.29.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
42.340.438.433.336.230.630.6
OPM
OPM%
31.532.931.524.927.922.422.2
NPM
NPM%
12.216.316.110.214.013.110.3
ROCE
ROCE%
18.724.930.216.423.814.814.8
ROE
ROE%
21.334.833.015.618.814.914.9
ROA
ROA%
7.011.914.57.011.39.59.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4,0463,9194,5548,1923,4934,711
Price To Earnings
Price To Earnings
16.011.123.322.910.517.4
Price To Sales
Price To Sales
2.61.82.43.21.41.8
Price To Book
Price To Book
5.63.73.64.31.62.1
EV To EBITDA
EV To EBITDA
9.86.911.412.37.29.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
42.340.438.433.336.230.630.6
OPM
OPM%
31.532.931.524.927.922.422.2
NPM
NPM%
12.216.316.110.214.013.110.3
ROCE
ROCE%
18.724.930.216.423.814.814.8
ROE
ROE%
21.334.833.015.618.814.914.9
ROA
ROA%
7.011.914.57.011.39.59.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Epigral Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/9818p93698z63ixuj5f7q54u.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/txel5hs5npjnzw60slyjv2ko.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/n7slz3f1hk5tc4pwh5fjvjt6.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/2vtsejkfxupok0m3vln2ckus.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/kiok7ov7p0luscvf1ojmc855.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/zgbm3np76xvrkjwo0fu5khd2.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/foz274tuv6xxqx80zfxc57cu.pdf
  • Q1 FY2025 Earnings Call Transcript (Jun 2024, PDF): https://www.stockscans.in/document/49elnbc6yc7jprz1173vd2p4.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/vumnpcls6bcq4jl4pv5o9rwi.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/fjsaacryqkawrp40p4ek78ka.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/xkbxqp9m4nbe70ov99jngnzb.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/y10w7q57yd4qx6ftgn8zc9s6.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/w4z7x4jwgyhmro450yik2jx0.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/lej23r5rfr4rd124d3tukmfl.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/mmvyt00i2tgqa5v3gtl4txhp.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/mzvt4a6fq8no0vvo0ih215xa.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/zysad0fwpbv4g72ywr3k2wd8.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/du1jwjpxoze0qoyw4tce0rp4.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/csre3j7py0wiptmvn7tg49q4.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/nk6vaspoi4s1cov7o8eh78yd.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/rn5oi4pxbmko4kzq8vp28bw2.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/pw8nm1sts5c77qhcammhqf2l.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/2biqvvlbcc5i80h504z5705b.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/7nycudnqvo1bytlc7nbcjhhl.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/hnp7of20blbnplon7vvw6w5q.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/y9y97bj2qanw90qzcyhtpd13.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/63v0jcs8pvxdojos6emn43sr.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/9izhm3h6lslhvrteinax2gdq.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/qvehzmw0ilgf1crxoxrdjord.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/rjcvzvqt8pr81tscg8z8dabs.pdf

Concall Transcript Summaries — Epigral Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AEPIGRAL/transcript-notes/202606/9818p93698z63ixuj5f7q54u.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AEPIGRAL/transcript-notes/202603/txel5hs5npjnzw60slyjv2ko.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AEPIGRAL/transcript-notes/202512/n7slz3f1hk5tc4pwh5fjvjt6.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AEPIGRAL/transcript-notes/202509/2vtsejkfxupok0m3vln2ckus.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AEPIGRAL/transcript-notes/202503/kiok7ov7p0luscvf1ojmc855.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AEPIGRAL/transcript-notes/202412/zgbm3np76xvrkjwo0fu5khd2.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AEPIGRAL/transcript-notes/202409/foz274tuv6xxqx80zfxc57cu.pdf
  • Q1 FY2025 Concall Transcript Summary (Jun 2024): https://www.stockscans.in/company/NSE%3AEPIGRAL/transcript-notes/202406/49elnbc6yc7jprz1173vd2p4.pdf